Bill Sponsor
House Bill 525
116th Congress(2019-2020)
Strengthening the Health Care Fraud Prevention Task Force Act of 2019
Active
Active
Passed House on Feb 25, 2019
Overview
Text
Introduced
Jan 11, 2019
Latest Action
Feb 26, 2019
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
525
Congress
116
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Sponsorship by Party
Republican
Oregon
Democrat
Massachusetts
Democrat
New Jersey
House Votes (1)
Senate Votes (0)
checkPassed on February 25, 2019
Status
Passed
Type
Voice Vote
Voice Vote
A vote in which the presiding officer states the question, then asks those in favor and against to say "Yea" or "Nay," respectively, and announces the result according to his or her judgment. The names or numbers of senators voting on each side are not recorded.
Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.(text: CR H2053-2054)
Summary

Strengthening the Health Care Fraud Prevention Task Force Act of 2019

This bill establishes statutory authority and requirements for a partnership between health insurance plans, government agencies, law enforcement, and health care organizations in order to detect and prevent health care waste, fraud, and abuse. The partnership must be established under the Health Care Fraud and Abuse Control Program, which is administered by the Department of Health and Human Services (HHS) and the Department of Justice (DOJ). Among other requirements, the partnership must (1) promote data sharing between partners, (2) analyze data to identify fraudulent practices, (3) refer potential criminal cases to law enforcement, and (4) conduct education and outreach.

Currently, HHS and DOJ administer the Healthcare Fraud Prevention Partnership. The purpose of the partnership is to address health care fraud through voluntary data sharing between public and private sectors; the partnership was created in 2012 through agency action. The bill transfers all functions, personnel, assets, liabilities, and administrative actions of this partnership to the partnership established under the bill.

Text (3)
February 26, 2019
February 25, 2019
January 11, 2019
Actions (10)
02/26/2019
Received in the Senate and Read twice and referred to the Committee on Finance.
02/25/2019
Motion to reconsider laid on the table Agreed to without objection.
02/25/2019
On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H2053-2054)
02/25/2019
Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.(text: CR H2053-2054)
02/25/2019
DEBATE - The House proceeded with forty minutes of debate on H.R. 525.
02/25/2019
Considered under suspension of the rules. (consideration: CR H2053-2055)
02/25/2019
Mr. Engel moved to suspend the rules and pass the bill.
01/25/2019
Referred to the Subcommittee on Health.
01/11/2019
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
01/11/2019
Introduced in House
Public Record
Record Updated
Nov 1, 2022 4:32:53 PM